CTOs on the Move

McNeil Consumer Healthcare

www.mcneilcanada.com

 
McNeil Consumer Healthcare is a Guelph, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

River Edge Behavioral Health Center

River Edge Behavioral Health Center has been providing mental health, mental retardation and substance abuse services to the citizens of Middle Georgia since 1994. River Edge strives to be the leader in behavioral healthcare providing comprehensive

Hometrak

Hometrak is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Minnetronix

Minnetronix is committed to delivering high quality products and services. We believe that a quality system should be a tool for superior systems design and manufacturing, not a barrier. Our quality system reflects this philosophy. Minnetronix has

getlunacare

Luna physical therapists come to you! We accept all major insurances and Medicare. Serving patients across the United States.

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.